Literature DB >> 6177369

Effects of prostaglandins and thromboxane analogues on bullock and dog iris sphincter preparations.

Y J Dong, R L Jones.   

Abstract

1 The bullock iris sphincter was contracted by low concentrations of prostaglandin E2 (PGE2), 16, 16-dimethyl PGE2 and 17,18,19,20-tetranor-16-p-chlorophenoxy PGE2. Other compounds with thromboxane-like actions, for example 11,9-epoxymethano PGH2, were also potent spasmogens, ZK 36374, a stable carbacyclin, was a partial agonist on the PGE-sensitive system of this tissue. 2 The thromboxane antagonist, EP 045, had little effect on the action of PGE2 and 16,16-dimethyl PGE2 on the bullock iris. 3 The dog iris sphincter was sensitive to PGF2 alpha but not to PGE2 and 11,9-epoxymethano PGH2. 4 16,16-dimethyl PGE2 had very low activity on the dog iris in contrast to its high activity on the bullock iris. The reverse was found with the 17,18,19,20-tetranor-16-m-trifluoromethylphenoxy analogue of PGF2 alpha (ICI 81008). This indicates a considerable selectivity of action of the two analogues. 5 The results are discussed in relation to the existing knowledge of prostanoid receptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6177369      PMCID: PMC2068741          DOI: 10.1111/j.1476-5381.1982.tb09200.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  The effect of precursors, products, and product analogs of prostaglandin cyclooxygenase upon iris sphincter muscle.

Authors:  C G Crawford; G W van Alphen; H W Cook; W E Lands
Journal:  Life Sci       Date:  1978-09-25       Impact factor: 5.037

2.  SMOOTH MUSCLE STIMULATING LIPIDS IN SHEEP IRIS. THE IDENTIFICATION OF PROSTAGLANDIN F 2A. PROSTAGLANDINS AND RELATED FACTORS 21.

Authors:  E ANGGARD; B SAMUELSSON
Journal:  Biochem Pharmacol       Date:  1964-02       Impact factor: 5.858

3.  Activity of prostaglandin E, F, A and B on sphincter, dilator and ciliary muscle preparations of the cat eye.

Authors:  G W van Alphen; M A Angel
Journal:  Prostaglandins       Date:  1975-02

4.  Potent luteolytic agents related to prostaglandin F2alpha.

Authors:  M Dukes; W Russell; A L Walpole
Journal:  Nature       Date:  1974-07-26       Impact factor: 49.962

5.  The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374)--equipotent to PGI2 in vitro.

Authors:  K Schrör; H Darius; R Matzky; R Ohlendorf
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

6.  The release of prostaglandin E2 from the bovine iris.

Authors:  J Posner; G Paterson
Journal:  Br J Pharmacol       Date:  1970-09       Impact factor: 8.739

7.  The biosynthesis of prostaglandin in pig eye iris.

Authors:  D A van Dorp; G H Jouvenaz; C B Struijk
Journal:  Biochim Biophys Acta       Date:  1967-04-04

8.  Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.

Authors:  R A Coleman; P P Humphrey; I Kennedy; G P Levy; P Lumley
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

9.  Prostaglandin E2 and the bovine sphincter pupillae.

Authors:  J Posner
Journal:  Br J Pharmacol       Date:  1973-11       Impact factor: 8.739

10.  A comparison of prostaglandin F2alpha and three 16-aryloxy analogues on the isolated rabbit jejunum.

Authors:  P J Welburn; R L Jones
Journal:  Prostaglandins       Date:  1978-02
  10 in total
  11 in total

1.  Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues.

Authors:  Y J Dong; R L Jones; N H Wilson
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

2.  Proceedings of the British Pharmacological Society, University of Cambridge, 6th-8th April, 1983. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

3.  Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.

Authors:  L Walch; V de Montpreville; C Brink; X Norel
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

4.  Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum.

Authors:  R A Lawrence; R L Jones; N H Wilson
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

5.  Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.

Authors:  R A Armstrong; R A Lawrence; R L Jones; N H Wilson; A Collier
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

6.  Competitive antagonism at thromboxane receptors in human platelets.

Authors:  R A Armstrong; R L Jones; V Peesapati; S G Will; N H Wilson
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

7.  Brain changes associated with thromboxane receptor antagonist SQ 29,548 treatment in a mouse model.

Authors:  Andrew A Rebel; Siri A Urquhart; Kendra L Puig; Atreyi Ghatak; Stephen A Brose; Mikhail Y Golovko; Colin K Combs
Journal:  J Neurosci Res       Date:  2015-02-22       Impact factor: 4.164

8.  Antagonism of the thromboxane-sensitive contractile systems of the rabbit aorta, dog saphenous vein and guinea-pig trachea.

Authors:  R L Jones; V Peesapati; N H Wilson
Journal:  Br J Pharmacol       Date:  1982-07       Impact factor: 8.739

9.  The action of prostanoid receptor agonists and antagonists on smooth muscle and platelets.

Authors:  R M Eglen; R L Whiting
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

10.  Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein.

Authors:  R A Lawrence; R L Jones
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.